These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29249801)

  • 21. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer.
    Wu J; Liu P; Tang H; Shuang Z; Qiu Q; Zhang L; Song C; Liu L; Xie X; Xiao X
    Curr Cancer Drug Targets; 2018; 18(4):382-389. PubMed ID: 29484998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
    Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
    Dutta P; Sarkissyan M; Paico K; Wu Y; Vadgama JV
    Breast Cancer Res Treat; 2018 Aug; 170(3):477-486. PubMed ID: 29594759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer.
    Wang J; Xu Y; Li L; Wang L; Yao R; Sun Q; Du G
    Cancer Med; 2017 Jan; 6(1):275-287. PubMed ID: 28028927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forkhead box C1 promotes metastasis and invasion of non-small cell lung cancer by binding directly to the lysyl oxidase promoter.
    Gong R; Lin W; Gao A; Liu Y; Li J; Sun M; Chen X; Han S; Men C; Sun Y; Liu J
    Cancer Sci; 2019 Dec; 110(12):3663-3676. PubMed ID: 31597217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of FOXE3 transcription factor as a potent oncogenic factor in triple-negative breast cancer.
    Wang H; Yang T; Yuan Y; Sun X
    Biochem Biophys Res Commun; 2020 Feb; 523(1):78-85. PubMed ID: 31831170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity.
    Gao L; Chen S; Hong M; Zhou W; Wang B; Qiu J; Xia J; Zhao P; Fu L; Wang J; Dai Y; Xie N; Yang Q; Huang HD; Gao X; Zou C
    Signal Transduct Target Ther; 2021 Jul; 6(1):250. PubMed ID: 34219129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.
    Wu R; Li K; Yuan M; Luo KQ
    Oncogene; 2021 Mar; 40(12):2165-2181. PubMed ID: 33627781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
    Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
    Jiang J
    Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p38-regulated FOXC1 stability is required for colorectal cancer metastasis.
    Zhang Y; Liao Y; Chen C; Sun W; Sun X; Liu Y; Xu E; Lai M; Zhang H
    J Pathol; 2020 Feb; 250(2):217-230. PubMed ID: 31650548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte elevated gene-1 increases invasiveness of NSCLC through up-regulating MMP7.
    Zhu R; Tian Y
    Cell Physiol Biochem; 2015; 37(3):1187-95. PubMed ID: 26418251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.
    Niu J; Xue A; Chi Y; Xue J; Wang W; Zhao Z; Fan M; Yang CH; Shao ZM; Pfeffer LM; Wu J; Wu ZH
    Oncogene; 2016 Mar; 35(10):1302-1313. PubMed ID: 26028030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.